LifeTech Scientific Corporation (HKG:1302)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Peripheral Vascular Diseases	814.37M
Peripheral Vascular Diseases Growth	4.23%
Structural Heart Diseases	572.01M
Structural Heart Diseases Growth	4.44%
Cardiac Pacing and Electrophysiology	27.12M
Cardiac Pacing and Electrophysiology Growth	-61.90%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
China	1.04B
China Growth	-5.34%
Europe	142.85M
Europe Growth	16.37%
Asia	106.80M
Asia Growth	43.35%
India	58.08M
India Growth	13.27%
South America	39.10M
South America Growth	5.53%
Africa	20.53M
Africa Growth	64.77%
Other	8.43M
Other Growth	43.24%